Diagnosis of hepatitis e

Nature Reviews Gastroenterology and Hepatology

Volumn 10, Issue 1, 2013, Pages 24-33

  Aggarwal, Rakesh ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS PROTEIN; VIRUS RNA;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBODY DETECTION; CELLULAR IMMUNITY; CHRONIC LIVER DISEASE; DEVELOPED COUNTRY; DIFFERENTIAL DIAGNOSIS; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSPOT ASSAY; GENETIC VARIABILITY; HEPATITIS E; HUMAN; IMMUNOASSAY; LIVER INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEROPREVALENCE; VIROLOGY; VIRUS DETECTION; VIRUS IMMUNITY; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

ANTIBODIES, VIRAL; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; RNA, VIRAL;

EID: 84871983688     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2012.187     Document Type: Review

References (82)

1. Khuroo, M. S. Study of an epidemic of non-A, non-B hepatitis: possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am. J. Med. 68, 818-824 (1980).
2. Balayan, M. S. et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 20, 23-31 (1983).
3. Bradley, D. W. et al. Enterically transmitted non-A, non-B hepatitis: serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27-34 nm viruslike particles. Proc. Natl Acad. Sci. USA 84, 6277-6281 (1987).
4. Reyes, G. R. et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 247, 1335-1339 (1990).
5. Tam, A. W. et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185, 120-131 (1991).
6. Mori, Y. & Matsuura, Y. Structure of hepatitis E viral particle. Virus Res. 161, 59-64 (2011).
7. Ahmad, I., Holla, R. P. & Jameel, S. Molecular virology of hepatitis E virus. Virus Res. 161, 47-58 (2011).
8. Meng, X. J. et al. in Virus taxonomy: classification and nomenclature of viruses: Ninth Report of the International Committee on Taxonomy of Viruses. (eds King, A. M. Q., Adams, M. J., Carstens, E. B. & Lefkowitz, E. J.) 1021-1028 (Elsevier, San Diego, 2011).
9. Purdy, M. A. & Khudyakov, Y. E. The molecular epidemiology of hepatitis E virus infection. Virus Res. 161, 31-39 (2011).
10. Lu, L., Li, C. & Hagedorn, C. H. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev. Med. Virol. 16, 5-36 (2006).
11. Li, T. C. et al. Serologic evidence for hepatitis E virus infection in mongoose. Am. J. Trop. Med. Hyg. 74, 932-936 (2006).
12. Cossaboom, C. M. et al. Cross-species infection of pigs with a novel rabbit, but not rat, strain of hepatitis E virus isolated in the United States. J. Gen. Virol. 93, 1687-1695 (2012).
13. Drexler, J. F. et al. Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae. J. Virol. 86, 9134-9147 (2012).
14. Batts, W., Yun, S., Hedrick, R. & Winton J. A novel member of the family Hepeviridae from cutthroat trout (Oncorhynchus clarkii). Virus Res. 158, 116-123 (2011).
15. Takahashi, M. et al. Analysis of the full-length genome of a hepatitis E virus isolate obtained from a wild boar in Japan that is classifiable into a novel genotype. J. Gen. Virol. 92, 902-908 (2011).
16. Wahi, P. N. & Arora, M. M. Epidemic hepatitis. N. Engl. J. Med. 248, 451-454 (1953).
17. Vishwanathan, R. Infectious hepatitis in Delhi (1955-56): a critical study: epidemiology. Indian J. Med. Res. 45 (Suppl. 1), 1-29 (1957).
18. Teo, C. G. Fatal outbreaks of jaundice in pregnancy and the epidemic history of hepatitis E. Epidemiol. Infect. 140, 767-787 (2012).
19. Aggarwal, R. & Naik, S. Epidemiology of hepatitis E: current status. J. Gastroenterol. Hepatol. 24, 1484-1493 (2009).
20. Aggarwal, R. & Jameel, S. Hepatitis E. Hepatology 54, 2218-2226 (2011).
21. Aggarwal, R. Clinical presentation of hepatitis E. Virus Res. 161, 15-22 (2011).
22. Kumar, A. et al. Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region. Indian J. Gastroenterol. 23, 59-62 (2004).
23. Kumar Acharya, S. et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J. Hepatol. 46, 387-394 (2007).
24. Dalton, H. R. et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment. Pharmacol. Ther. 26, 1429-1435 (2007).
25. Davern, T. J. et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 141, 1665-1672 (2011).
26. Poff, J. A. et al. Frequency and histopathologic basis of hepatic surface nodularity in patients with fulminant hepatic failure. Radiology 249, 518-523 (2008).
27. Arankalle, V. A. et al. Aetiological association of a virus like particle with enterically transmitted non-A, non-B hepatitis. Lancet 1, 550-554 (1988).
28. Kane, M. A. et al. Epidemic non-A, non-B hepatitis in Nepal: recovery of a possible etiologic agent and transmission studies in marmosets. JAMA 252, 3140-3145 (1984).
29. Jothikumar, N., Cromeans, T. L., Robertson, B. H., Meng, X. J. & Hill, V. R. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J. Virol. Methods 131, 65-71 (2006).
30. Baylis, S. A. et al. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J. Clin. Microbiol. 49, 1234-1239 (2011).
31. Lan, X. et al. Reverse transcription-loop-mediated isothermal amplification assay for rapid detection of hepatitis E virus. J. Clin. Microbiol. 47, 2304-2306 (2009).
32. Aggarwal, R., Kini, D., Sofat, S., Naik, S. R. & Krawczynski, K. Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet 356, 1081-1082 (2000).
33. Huang, S. et al. Profile of acute infectious markers in sporadic hepatitis E. PLoS ONE 5, e13560 (2010).
34. Dalton, H. R., Bendall, R. P., Keane, F. E., Tedder, R. S. & Ijaz, S. Persistent carriage of hepatitis E virus in patients with HIV infection. N. Engl. J. Med. 361, 1025-1027 (2009).
35. Kamar, N. et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am. J. Transplant. 10, 1321-1324 (2010).
36. Kamar, N. et al. Hepatitis E virus and neurologic disorders. Emerg. Infect. Dis. 17, 173-179 (2011).
37. Tei, S., Kitajima, N., Takahashi, K. & Mishiro, S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 362, 371-373 (2003).
38. Colson, P. et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J. Infect. Dis. 202, 825-834 (2010).
39. Zhang, F. et al. Detection of HEV antigen as a novel marker for the diagnosis of hepatitis E. J. Med. Virol. 78, 1441-1448 (2006).
40. Zhao, C. et al. Relationships among viral diagnostic markers and markers of liver function in acute hepatitis E. J. Gastroenterol. 44, 139-145 (2009).
41. Krawczynski, K. & Bradley, D. W. Enterically transmitted non-A, non-B hepatitis: identification of virus-associated antigen in experimentally infected cynomolgus macaques. J. Infect. Dis. 159, 1042-1049 (1989).
42. Krawczynski, K., Meng, X. J. & Rybczynska, J. Pathogenetic elements of hepatitis E and animal models of HEV infection. Virus Res. 161, 78-83 (2011).
43. Favorov, M. O. et al. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J. Med. Virol. 36, 246-250 (1992).
44. Myint, K. S. et al. Hepatitis E antibody kinetics in Nepalese patients. Trans. R. Soc. Trop. Med. Hyg. 100, 938-941 (2006).
45. Khuroo, M. S., Kamili, S., Dar, M. Y., Moecklii, R. & Jameel, S. Hepatitis E and long-term antibody status. Lancet 341, 1355 (1993).
46. Bryan, J. P. et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J. Infect. Dis. 170, 517-521 (1994).
47. Herremans, M., Duizer, E., Jusic, E. & Koopmans, M. P. Detection of hepatitis E virus-specific immunoglobulin A in patients infected with hepatitis E virus genotype 1 or 3. Clin. Vaccine Immunol. 14, 276-280 (2007).
48. Takahashi, M. et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J. Clin. Microbiol. 43, 49-56 (2005).
49. Riddell, M. A., Li, F. & Anderson, D. A. Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies. J. Virol. 74, 8011-8017 (2000).
50. Zhang, J. Z. et al. Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J. Med. Virol. 64, 125-132 (2001).
51. Khudyakov, Y. & Kamili, S. Serological diagnostics of hepatitis E virus infection. Virus Res. 161, 84-92 (2011).
52. Kaur, M. et al. Human linear B-cell epitopes encoded by the hepatitis E virus include determinants in the RNA-dependent RNA polymerase. Proc. Natl Acad. Sci. USA 89, 3855-3858 (1992).
53. Zhang, J. et al. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine 23, 2881-2892 (2005).
54. Emerson, S. U. et al. Putative neutralization epitopes and broad cross-genotype neutralization of hepatitis E virus confirmed by a quantitative cell-culture assay. J. Gen. Virol. 87, 697-704 (2006).
55. Herremans, M., Bakker, J., Duizer, E., Vennema, H. & Koopmans, M. P. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin. Vaccine Immunol. 14, 562-568 (2007).
56. Ma, H. et al. Hepatitis E virus ORF3 antigens derived from genotype 1 and 4 viruses are detected with varying efficiencies by an anti-HEV enzyme immunoassay. J. Med. Virol. 83, 827-832 (2011).
57. Li, F. et al. Recombinant subunit ORF2.1 antigen and induction of antibody against immunodominant epitopes in the hepatitis E virus capsid protein. J. Med. Virol. 60, 379-386 (2000).
58. Robinson, R. A. et al. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr. Purif. 12, 75-84 (1998).
59. Tsarev, S. A. et al. ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J. Infect. Dis. 168, 369-378 (1993).
60. Zhang, M. et al. Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells. Vaccine 20, 853-857 (2001).
61. Jameel, S., Zafrullah, M., Ozdener, M. H. & Panda, S. K. Expression in animal cells and characterization of the hepatitis E virus structural proteins. J. Virol. 70, 207-216 (1996).
62. Ma, Y. et al. Expression of ORF2 partial gene of hepatitis E virus in tomatoes and immunoactivity of expression products. World J. Gastroenterol. 9, 2211-2115 (2003).
63. Zhou, Y. X. et al. A truncated hepatitis E virus ORF2 protein expressed in tobacco plastids is immunogenic in mice. World J. Gastroenterol. 12, 306-312 (2006).
64. Sehgal, D., Malik, P. S. & Jameel, S. Purification and diagnostic utility of a recombinant hepatitis E virus capsid protein expressed in insect larvae. Protein Expr. Purif. 27, 27-34 (2003).
65. Jiménez de Oya, N. et al. Serological immunoassay for detection of hepatitis E virus on the basis of genotype 3 open reading frame 2 recombinant proteins produced in Trichoplusia ni larvae. J. Clin. Microbiol. 47, 3276-3282 (2009).
66. Khudyakov, Y. E. et al. Artificial mosaic protein containing antigenic epitopes of hepatitis E virus. J. Virol. 68, 7067-7074 (1994).
67. Ulanova, T. I. et al. A new artificial antigen of the hepatitis E virus. J. Immunoassay Immunochem. 30, 18-39 (2009).
68. Yu, C., Engle, R. E., Bryan, J. P., Emerson, S. U. & Purcell, R. H. Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay. Clin. Diagn. Lab. Immunol. 10, 579-586 (2003).
69. Chen, H. Y. et al. Comparison of a new immunochromatographic test to enzyme-linked immunosorbent assay for rapid detection of immunoglobulin M antibodies to hepatitis E virus in human sera. Clin. Diagn. Lab. Immunol. 12, 593-598 (2005).
70. Myint, K. S. et al. Evaluation of a new rapid immunochromatographic assay for serodiagnosis of acute hepatitis E infection. Am. J. Trop. Med. Hyg. 73, 942-946 (2005).
71. Legrand-Abravanel, F. et al. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin. Vaccine Immunol. 16, 772-774 (2009).
72. Hu, W. P. et al. Double-antigen enzyme-linked immunosorbent assay for detection of hepatitis E virus-specific antibodies in human or swine sera. Clin. Vaccine Immunol. 15, 1151-1157 (2008).
73. Dong, C. et al. Restricted enzooticity of hepatitis E virus genotypes 1 to 4 in the United States. J. Clin. Microbiol. 49, 4164-4172 (2011).
74. Bendall, R., Ellis, V., Ijaz, S., Ali, R. & Dalton, H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J. Med. Virol. 82, 799-805 (2010).
75. Drobeniuc, J. et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin. Infect. Dis. 51, e24-e27 (2010).
76. Mast, E. E., Alter, M. J., Holland, P. V. & Purcell, R. H. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 27, 857-861 (1998).
77. Park, H. K. et al. Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays. BMC Infect. Dis. 12, 142 (2012).
78. Mansuy, J. M. et al. Hepatitis E virus antibodies in blood donors, France. Emerg. Infect. Dis. 17, 2309-2312 (2011).
79. Loong, T. W. Understanding sensitivity and specificity with the right side of the brain. BMJ 327, 716-719 (2003).
80. Rangaka, M. X. et al. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect. Dis. 12, 45-55 (2012).
81. Shata, M. T. et al. Characterization of hepatitis E-specific cell-mediated immune response using IFN-γ ELISPOT assay. J. Immunol. Methods 328, 152-161 (2007).
82. Husain, M. M. et al. Evidence of hepatitis E virus exposure among seronegative healthy residents of an endemic area. Intervirology 54, 139-143 (2010).